Response-adapted anti-PD1 based salvage therapy for Hodgkin lymphoma with nivolumab +/- ICE (NICE). Mei MG, Lee HJ, Palmer J, Chen RW, et al. Blood 2022 Mar 22. pii: 484451. doi: 10.1182/blood.2022015423.

Read + Share

Amedeo Smart

Independent Medical Education

Mei MG, Lee HJ, Palmer J, Chen RW, et al. Response-adapted anti-PD1 based salvage therapy for Hodgkin lymphoma with nivolumab +/- ICE (NICE). Blood 2022 Mar 22. pii: 484451. doi: 10.1182/blood.2022015423.
PMID: 35316328